Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Halberd Corp HALB

Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the... see more

Recent & Breaking News (OTCPK:HALB)

Halberd Corporation CEO Answers Shareholders' Questions Regarding Covid-19 Treatment

Accesswire August 18, 2020

Halberd Corporation Adds Edson Brito to Scientific Advisory Board

Accesswire August 12, 2020

Halberd Corporation Adds Dr. Abdon Nanhay to Scientific Advisory Board Furthering the Fight Against Covid-19 Internationally

Accesswire August 10, 2020

Halberd Corporation Adds Dr. Gregory George as Member of Scientific Advisory Board

Accesswire August 6, 2020

Halberd Corporation Secures $2 Million for Covid-19 Research

Accesswire August 4, 2020

Retired NFL Great Carl Eller Joins Halberd Corporation

Accesswire July 27, 2020

Halberd Corporation CTO, Dr. Patricio Reyes, Presents Information at Virtual Event on Covid-19's Effects on Neurological Functions

Accesswire July 22, 2020

Halberd Advances the Treatment of COVID-19 Utilizing Laser Technology

Accesswire July 16, 2020

Halberd Corp - Update July 13, 2020 - Addresses Certain Issues

Accesswire July 13, 2020

COVID-19 Cytokine Storm, Coronavirus' Deadliest Stage - Halberd's US Patent Pending Treatment Now Explained!

Accesswire July 7, 2020

Halberd Method for Treating and Curing the COVID-19 Infection Explained

Accesswire June 29, 2020

NFL Retired Players Association's Chief Medical Officer Joins Halberd Corporation to Lead COVID-19 Efforts Effective Immediately!

Accesswire June 22, 2020

Halberd Designated "Pink Current Information" by OTC and Continues Technology Progress

Accesswire June 15, 2020

Halberd Corporation Appoints Dr. Patricio Reyes to Scientific Advisory Board

Accesswire June 9, 2020

Halberd Corp. Announces Correction/Clarification to Eliminate Name Confusion

Accesswire June 5, 2020

Technology Health Announces Full Compliance With OTC Reporting Requirements And Immediate Plans To Develop Covid-19 Treatment

Accesswire June 3, 2020

Premier Biomedical, Technology Health, and Datatecnics Agree to Collaborate on Extracorporeal "Map and Zap(TM)" Coronavirus Treatment

Accesswire May 12, 2020

Premier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier's Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction Patch(TM)

Accesswire April 8, 2020

Halberd Announces Agreement to Retire 192,000,000 Outstanding Common Shares and Acquisition/Joint Venture to Be Announced, in Detail, This Week

Newsfile April 6, 2020

Halberd Moves Forward - Announces New CEO, Commences Process to Become Current, Holding Company Reorganization

Newsfile April 3, 2020